Nov 1 (Reuters) - Activist investor Politan Capital Management had nominated candidates to Azenta's board last month and was working with the biotechnology company to address certain issues, a company filing disclosed on Wednesday. (Reporting by Svea Herbst-Bayliss and Pratik Jain; Editing by Anil D'Silva)